Cargando…

Practical guidance for planning resources required to support publicly-funded adaptive clinical trials

Adaptive designs are a class of methods for improving efficiency and patient benefit of clinical trials. Although their use has increased in recent years, research suggests they are not used in many situations where they have potential to bring benefit. One barrier to their more widespread use is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wason, James M. S., Dimairo, Munyaradzi, Biggs, Katie, Bowden, Sarah, Brown, Julia, Flight, Laura, Hall, Jamie, Jaki, Thomas, Lowe, Rachel, Pallmann, Philip, Pilling, Mark A., Snowdon, Claire, Sydes, Matthew R., Villar, Sofía S., Weir, Christopher J., Wilson, Nina, Yap, Christina, Hancock, Helen, Maier, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364623/
https://www.ncbi.nlm.nih.gov/pubmed/35945610
http://dx.doi.org/10.1186/s12916-022-02445-7
_version_ 1784765182230134784
author Wason, James M. S.
Dimairo, Munyaradzi
Biggs, Katie
Bowden, Sarah
Brown, Julia
Flight, Laura
Hall, Jamie
Jaki, Thomas
Lowe, Rachel
Pallmann, Philip
Pilling, Mark A.
Snowdon, Claire
Sydes, Matthew R.
Villar, Sofía S.
Weir, Christopher J.
Wilson, Nina
Yap, Christina
Hancock, Helen
Maier, Rebecca
author_facet Wason, James M. S.
Dimairo, Munyaradzi
Biggs, Katie
Bowden, Sarah
Brown, Julia
Flight, Laura
Hall, Jamie
Jaki, Thomas
Lowe, Rachel
Pallmann, Philip
Pilling, Mark A.
Snowdon, Claire
Sydes, Matthew R.
Villar, Sofía S.
Weir, Christopher J.
Wilson, Nina
Yap, Christina
Hancock, Helen
Maier, Rebecca
author_sort Wason, James M. S.
collection PubMed
description Adaptive designs are a class of methods for improving efficiency and patient benefit of clinical trials. Although their use has increased in recent years, research suggests they are not used in many situations where they have potential to bring benefit. One barrier to their more widespread use is a lack of understanding about how the choice to use an adaptive design, rather than a traditional design, affects resources (staff and non-staff) required to set-up, conduct and report a trial. The Costing Adaptive Trials project investigated this issue using quantitative and qualitative research amongst UK Clinical Trials Units. Here, we present guidance that is informed by our research, on considering the appropriate resourcing of adaptive trials. We outline a five-step process to estimate the resources required and provide an accompanying costing tool. The process involves understanding the tasks required to undertake a trial, and how the adaptive design affects them. We identify barriers in the publicly funded landscape and provide recommendations to trial funders that would address them. Although our guidance and recommendations are most relevant to UK non-commercial trials, many aspects are relevant more widely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02445-7.
format Online
Article
Text
id pubmed-9364623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93646232022-08-11 Practical guidance for planning resources required to support publicly-funded adaptive clinical trials Wason, James M. S. Dimairo, Munyaradzi Biggs, Katie Bowden, Sarah Brown, Julia Flight, Laura Hall, Jamie Jaki, Thomas Lowe, Rachel Pallmann, Philip Pilling, Mark A. Snowdon, Claire Sydes, Matthew R. Villar, Sofía S. Weir, Christopher J. Wilson, Nina Yap, Christina Hancock, Helen Maier, Rebecca BMC Med Correspondence Adaptive designs are a class of methods for improving efficiency and patient benefit of clinical trials. Although their use has increased in recent years, research suggests they are not used in many situations where they have potential to bring benefit. One barrier to their more widespread use is a lack of understanding about how the choice to use an adaptive design, rather than a traditional design, affects resources (staff and non-staff) required to set-up, conduct and report a trial. The Costing Adaptive Trials project investigated this issue using quantitative and qualitative research amongst UK Clinical Trials Units. Here, we present guidance that is informed by our research, on considering the appropriate resourcing of adaptive trials. We outline a five-step process to estimate the resources required and provide an accompanying costing tool. The process involves understanding the tasks required to undertake a trial, and how the adaptive design affects them. We identify barriers in the publicly funded landscape and provide recommendations to trial funders that would address them. Although our guidance and recommendations are most relevant to UK non-commercial trials, many aspects are relevant more widely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02445-7. BioMed Central 2022-08-10 /pmc/articles/PMC9364623/ /pubmed/35945610 http://dx.doi.org/10.1186/s12916-022-02445-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Wason, James M. S.
Dimairo, Munyaradzi
Biggs, Katie
Bowden, Sarah
Brown, Julia
Flight, Laura
Hall, Jamie
Jaki, Thomas
Lowe, Rachel
Pallmann, Philip
Pilling, Mark A.
Snowdon, Claire
Sydes, Matthew R.
Villar, Sofía S.
Weir, Christopher J.
Wilson, Nina
Yap, Christina
Hancock, Helen
Maier, Rebecca
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
title Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
title_full Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
title_fullStr Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
title_full_unstemmed Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
title_short Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
title_sort practical guidance for planning resources required to support publicly-funded adaptive clinical trials
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364623/
https://www.ncbi.nlm.nih.gov/pubmed/35945610
http://dx.doi.org/10.1186/s12916-022-02445-7
work_keys_str_mv AT wasonjamesms practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT dimairomunyaradzi practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT biggskatie practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT bowdensarah practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT brownjulia practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT flightlaura practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT halljamie practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT jakithomas practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT lowerachel practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT pallmannphilip practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT pillingmarka practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT snowdonclaire practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT sydesmatthewr practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT villarsofias practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT weirchristopherj practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT wilsonnina practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT yapchristina practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT hancockhelen practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials
AT maierrebecca practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials